Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NZQQB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2022135332A1 1-9
|
|||||
| Synonyms |
WO2022135332A1
Click to Show/Hide
|
|||||
| Organization |
Duality Biologics
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.35
|
|||||
| Structure |
|
|||||
| Antibody Name |
Adalimumab
|
Antibody Info | ||||
| Antigen Name |
Tumor necrosis factor (TNF)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
WO2022135332A1_1-9 linker
|
|||||